PATENT CLAIM ANALYSIS

Application Number: 15777333
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "282000"]

Abstract:
The present invention provides a transdermal delivery device comprising a pharmaceutical composition, wherein said composition comprises a N-oxide derivative of an opioid antagonist, or a salt thereof, and an opioid agonist or salt thereof.

Claim (Index 3):
The device as claimed in  claim 1 , wherein said N-oxide derivative is of formula (IIa): wherein each of R 1 , R 2 , R 3 , R 4  and R 5  are as defined in  claim 1 .

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.40741
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15170201', '14585438', '12786686', '12176279', '13543022']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7540853291775225
- 35 USC 102 Novelty (BERT): 0.525341569307491
- Combined Prediction Score: 0.7312109531905194
- Mean Citation Score: 254.688388
- Max Citation Score: 257.35855
- Similarity Product: 143.927860389781

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test